T. Rowe Price Associates’s PHARMACYCLICS INC PCYC Stock Holding History

T. Rowe Price Associates’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,599,467	Closed	-$2.46B	–	2602
2015 Q1	$2.46B	Sell	9,599,467 -287,017	-3%	-$55.4M	0.51%	34
2014 Q4	$1.21B	Buy	9,886,484 +60,592	+0.6%	+$7.74M	0.26%	98
2014 Q3	$1.15B	Buy	9,825,892 +2,074,585	+27%	+$236M	0.25%	102
2014 Q2	$695M	Buy	7,751,307 +1,048,516	+16%	+$98.4M	0.15%	169
2014 Q1	$672M	Sell	6,702,791 -942,949	-12%	-$123M	0.15%	174
2013 Q4	$809M	Sell	7,645,740 -594,335	-7%	-$72.1M	0.19%	137
2013 Q3	$1.14B	Buy	8,240,075 +1,011,415	+14%	+$112M	0.28%	88
2013 Q2	$574M	Buy	+7,228,660	New	+$591M	0.15%	173

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

T. Rowe Price Associates's PCYC Position: Q2 2015 in Review

T. Rowe Price Associates sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 9,599,467 shares — an estimated $2.46B sold.

T. Rowe Price Associates first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $2.46B in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

T. Rowe Price Associates reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
T. Rowe Price Associates sold 9,599,467 PHARMACYCLICS INC shares in Q2 2015, an estimated $2.46B.
T. Rowe Price Associates first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
T. Rowe Price Associates's PHARMACYCLICS INC position peaked at $2.46B in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.